Clinical Genome Variant Analysis 2 (GENE90025)

Graduate courseworkPoints: 6.25On Campus (Parkville)

You’re viewing the 2025 Handbook:
Or view archived Handbooks

Overview

Availability
August
FeesLook up fees

Clinical Genome Variant Analysis 2 is designed to broaden and further develop the basic understanding and principles of variant interpretation taught in Clinical Genome Variant Analysis 1. Application of software and genomic database for collation of evidence for interpretation will be covered in detail.

The subject will be taught as an intensive, blended (on-line and face-to-face) subject, commencing in the first half of the semester.

The subject provides a sound foundation for participation in multidisciplinary clinical discussions on genomic testing and analysis, and would be useful preparatory learning for laboratory scientists and clinical staff training in variant interpretation.

Completion of Clinical Genome Variant Analysis 1 to a grade of 70% or higher is a prerequisite for this subject.

Intended learning outcomes

On completion of the subject, students should be able to:

  • Interpret human genomic information by using evidence to classify variants based on guidelines; and
  • Interpret human genomic information in a clinical setting by describing how the process of clinical genome variant analysis is integral to generation of a clinical report.

Generic skills

  • Be proficient in academic writing
  • Be confident in public speaking and presenting academic content to an audience
  • Be meaningful contributors to teams; working in small and larger group settings
  • Demonstrate critical thinking skills in approaching issues in the community
  • Use proficient reading skills to inform areas of work
  • Operate as responsible, professional and ethical members of the community, offering well-rounded knowledge and skills to benefit society.

Last updated: 14 March 2025